NCT03885921View on ClinicalTrials.gov

Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019)

PHASE3CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 25, 2000

Primary Completion Date

July 8, 2003

Study Completion Date

July 8, 2003

Conditions
Hypercholesterolemia
Interventions
DRUG

Ezetimibe

oral tablet

DRUG

Atorvastatin

oral tablet

DRUG

Simvastatin

oral tablet

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT03885921 - Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019) | Biotech Hunter | Biotech Hunter